Alopecia Areata Awareness Month 2023 - Recording from Sept 6/23 Live Public Webinar

Описание к видео Alopecia Areata Awareness Month 2023 - Recording from Sept 6/23 Live Public Webinar

On Sept 6 2023 Dr Donovan hosted a public webinar as part of Alopecia Areata Awareness Month. This video addresses 13 questions pertaining to alopecia areata. Questions are shown below with time stamps.

WEBINAR QUESTTIONS:

Question 1 (starts at 3:05): Is the rate of alopecia areata going up ?


Question 2 (starts at 7:32): What blood tests should be ordered for someone with alopecia areata?


Question 3 (starts at 11:53): Do JAK inhibitors cure alopecia areata?


Question 4 (starts at 16:05): What treatments are possible for eyelash loss?


Question 5 (starts at 18:20): What other medical problems do patients with alopecia areata have?


Question 6 (starts at 21:18): My son is 3 years old and Alopecia. 1 year ago, hair loss started and his hair and eyebrows completely fell out. In the tests , it was determined that his intestinal flora was very disordered and he has lactose and gluten intolerance. There are some doctors who have found that Intestinal Flora Disorder and Leaky Gut Syndrome can cause some autoimmune diseases. I would like to know your thoughts on this subject.



Question 7 (starts at 28:42): Should I ask for a biopsy to prove the diagnosis of alopecia areata?



Question 8 (starts at 30:58): I am a 37 year old female and have alopecia areata. Will I pass this on to my children?


Question 9 (starts at 33:36): Does stress cause alopecia areata? I hear mixed views.

Question 10 (starts at 37:42): My 3 year old developed a small area of alopecia over the summer. What treatment is considered best?



Question 11 (starts at 44:24): Does low vitamin D make alopecia worse?

Question 12 (starts at 47:16): My alopecia areata is becoming scarring. How is this possible?


Question 13 (starts at 51:16): Do you see loss of efficacy over time of JAK inhibitors and if so what would be the reason

Комментарии

Информация по комментариям в разработке